Latest surveillance data shows a rise in antibiotic resistant infections and associated deaths

The latest national surveillance data, announced at the UK Health Security Agency (UKHSA) annual conference in Leeds today, shows that an estimated 58,224 people in England had an antibiotic resistant infection in 2022 – a rise of 4% since 2021 (55,792).

Federal Psychedelics Update: $75M Grant Program, NIDA’s Special Interest In Reform, And More

In view of the most recent Congressional advancement in psychedelics regulation, a bipartisan bill creating a $75 million research grant program for the potential treatment of mental health

June 15, 2023

Dietary choices are linked to higher rates of preeclampsia among Latinas

For pregnant Latinas, food choices could reduce the risk of preeclampsia, a dangerous type of high blood pressure, and a diet based on cultural food

April 5, 2024

Not ‘TIL’ 2024: Iovance’s lifileucel faces yet another approval delay, this time due to FDA resource constraints

Iovance Biotherapeutics’ bid for approval of its melanoma therapy has been hit with its fourth year of delay, as FDA resource constraints forced the agency

September 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.